Moderna, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Moderna, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q4 2024.
  • Moderna, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $104M, a 31.6% increase year-over-year.
  • Moderna, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $429M, a 40.7% increase year-over-year.
  • Moderna, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $429M, a 40.7% increase from 2023.
  • Moderna, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $305M, a 35% increase from 2022.
  • Moderna, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $226M, a 59.2% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $429M $104M +$25M +31.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-21
Q3 2024 $404M $112M +$35M +45.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $369M $112M +$38M +51.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $331M $101M +$26M +34.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $305M $79M +$17M +27.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-21
Q3 2023 $288M $77M +$7M +10% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $281M $74M +$24M +48% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $257M $75M +$31M +70.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $226M $62M +$25M +67.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-21
Q3 2022 $201M $70M +$30M +75% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $171M $50M +$15M +42.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $156M $44M +$14M +46.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $142M $37M +$11M +42.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $131M $40M +$18M +81.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $113M $35M +$10M +40% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $103M $30M +$10M +50% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $93M $26M +$5.8M +28.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $87.2M $22M +$1.2M +5.75% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $86M $25M +$3.51M +16.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $82.5M $20M +$1.5M +8.13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $81M $20.2M -$11.4M -36.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $92.4M $20.8M +$6.08M +41.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $86.4M $21.5M +$7.14M +49.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $79.2M $18.5M +$6.65M +56.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $72.6M $31.6M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $14.7M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $14.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $11.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.